Cellink Life Sciences completes Nanoscribe acquisition

    June 1, 2021
    Nanoscribe specializes in 3D bioprinting based on two-photon polymerization technology.
    (Photo 100051973 / 3d © Keatanan Viya | Dreamstime.com)
    Dreamstime M 100051973 60b6307210b17

    On May 31, 2021, bioconvergence company Cellink Life Sciences (Gothenburg, Sweden) finalized its acquisition of Nanoscribe (Karlsruhe, Germany), a company focusing on development of high-precision 3D printers based on two-photon polymerization (2PP) technology. 

    The combination of the two companies’ technologies enables Cellink to offer 2PP products for several markets, such as bioprinting, microfluidics, micro-optics, micromechanics, biomedical engineering, and integrated photonics technologies, explains Erik Gatenholm, CEO of Cellink. One example, he says, is the sample preparation steps for single-cell genomics applications.

    Source: Cellink Life Sciences press release

    Continue Reading

    Sponsored Recommendations

    March 31, 2025
    Enhance your remote sensing capabilities with Chroma's precision-engineered optical filters, designed for applications such as environmental monitoring, geospatial mapping, and...
    March 31, 2025
    Designed for compatibility with a wide range of systems, Chroma's UV filters are engineered to feature high transmission, superior out-of-band blocking, steep edge transitions...
    March 31, 2025
    Discover strategies to balance component performance and system design, reducing development time and costs while maximizing efficiency.
    March 31, 2025
    Explore the essential role of optical filters in enhancing Raman spectroscopy measurements including the various filter types and their applications in improving signal-to-noise...

    Voice your opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!